Raltitrexed

3 registered clinical trials studyying Raltitrexed — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC NCT06427005	Meng Qiu	Phase 2
Unknown	Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients NCT05426811	China Medical University, China	Phase 1 / Phase 2
Completed	Raltitrexed in HIPEC NCT04761185	Fudan University	Phase 1